CIK 0001138639
INFN Infinera Corp
Insider trading from SEC Form 4. Last filing Mar 3, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Signals
Open-market buys and sells at Infinera Corp, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 70 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Sharon E Holt director | MOption exercise Common Stock | +36,697 | $0.00 | $0 | 268,871 | Mar 3, 2025 |
| Feb 28, 2025 | David F Welch director | MOption exercise Common Stockindirect: See Footnote | +100,001 | $0.00 | $0 | 532,871 | Mar 3, 2025 |
| Feb 28, 2025 | George Andrew Riedel director | MOption exercise Common Stock | +36,697 | $0.00 | $0 | 204,716 | Mar 3, 2025 |
| Feb 28, 2025 | Roop Kalyan Lakkaraju director | MOption exercise Common Stock | +36,697 | $0.00 | $0 | 130,851 | Mar 3, 2025 |
| Feb 28, 2025 | Nicholas Walden SVP, Worldwide Sales | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 234,641 | Mar 3, 2025 |
| Feb 28, 2025 | Paul J Milbury director | MOption exercise Common Stock | +36,697 | $0.00 | $0 | 229,628 | Mar 3, 2025 |
| Feb 28, 2025 | Christine Bucklin director | MOption exercise Common Stock | +36,697 | $0.00 | $0 | 171,716 | Mar 3, 2025 |
| Feb 28, 2025 | David W Heard Chief Executive Officer | AGrant or award Common Stock | +412,500 | $0.00 | $0 | 1,512,989 | Mar 3, 2025 |
| Feb 28, 2025 | Nancy Erba Chief Financial Officer | AGrant or award Common Stock | +117,500 | $0.00 | $0 | 693,722 | Mar 3, 2025 |
| Feb 27, 2025 | Regan J MacPherson Chief Legal Officer | AGrant or award Restricted Stock Unitsderivative | +75,132 | $0.00 | $0 | 75,132 | Mar 3, 2025 |
| Feb 28, 2025 | Greg Dougherty director | MOption exercise Common Stock | +36,697 | $0.00 | $0 | 253,318 | Mar 3, 2025 |
| Feb 28, 2025 | Nicholas Walden SVP, Worldwide Sales | DDisposition to issuer Common Stock | -234,641 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Christine Bucklin director | DDisposition to issuer Common Stock | -171,716 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | David F Welch director | DDisposition to issuer Common Stockindirect: See Footnote | -532,871 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | George Andrew Riedel director | DDisposition to issuer Common Stock | -204,716 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Roop Kalyan Lakkaraju director | DDisposition to issuer Common Stock | -130,851 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Regan J MacPherson Chief Legal Officer | AGrant or award Restricted Stock Unitsderivative | +153,334 | $0.00 | $0 | 153,334 | Mar 3, 2025 |
| Feb 28, 2025 | Greg Dougherty director | DDisposition to issuer Common Stock | -253,318 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Sharon E Holt director | DDisposition to issuer Common Stock | -268,871 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Paul J Milbury director | DDisposition to issuer Common Stock | -229,628 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | David W Heard Chief Executive Officer | DDisposition to issuer Common Stock | -1,512,989 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Nancy Erba Chief Financial Officer | DDisposition to issuer Common Stock | -693,722 | - | - | 0 | Mar 3, 2025 |
| Feb 27, 2025 | David W Heard Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +305,432 | $0.00 | $0 | 305,432 | Mar 3, 2025 |
| Feb 28, 2025 | Regan J MacPherson Chief Legal Officer | DDisposition to issuer Restricted Stock Unitsderivative | -393,466 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 27, 2025 | Nicholas Walden SVP, Worldwide Sales | AGrant or award Restricted Stock Unitsderivative | +47,365 | $0.00 | $0 | 47,365 | Mar 3, 2025 |
| Feb 28, 2025 | Paul J Milbury director | MOption exercise Restricted Stock Unitsderivative | -36,697 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | David F Welch director | DDisposition to issuer Common Stockindirect: See Footnote | -2,500 | - | - | 0 | Mar 3, 2025 |
| Feb 27, 2025 | Nancy Erba Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +68,600 | $0.00 | $0 | 68,600 | Mar 3, 2025 |
| Feb 28, 2025 | Greg Dougherty director | MOption exercise Restricted Stock Unitsderivative | -36,697 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | George Andrew Riedel director | MOption exercise Restricted Stock Unitsderivative | -36,697 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Christine Bucklin director | MOption exercise Restricted Stock Unitsderivative | -36,697 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Sharon E Holt director | MOption exercise Restricted Stock Unitsderivative | -36,697 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Roop Kalyan Lakkaraju director | MOption exercise Restricted Stock Unitsderivative | -36,697 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Nicholas Walden SVP, Worldwide Sales | AGrant or award Restricted Stock Unitsderivative | +96,668 | $0.00 | $0 | 96,668 | Mar 3, 2025 |
| Feb 28, 2025 | David W Heard Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +623,334 | $0.00 | $0 | 623,334 | Mar 3, 2025 |
| Feb 28, 2025 | David F Welch director | MOption exercise Restricted Stock Unitsderivative | -100,001 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Nancy Erba Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +140,000 | $0.00 | $0 | 140,000 | Mar 3, 2025 |
| Feb 28, 2025 | Nicholas Walden SVP, Worldwide Sales | DDisposition to issuer Restricted Stock Unitsderivative | -373,951 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Nancy Erba Chief Financial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -465,268 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | David W Heard Chief Executive Officer | DDisposition to issuer Restricted Stock Unitsderivative | -2,121,150 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 16, 2025 | Roop Kalyan Lakkaraju director | MOption exercise Common Stock | +6,478 | $0.00 | $0 | 94,154 | Feb 18, 2025 |
| Feb 16, 2025 | Roop Kalyan Lakkaraju director | MOption exercise Restricted Stock Unitsderivative | -6,478 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Jan 13, 2025 | Nancy Erba Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +95,000 | $0.00 | $0 | 95,000 | Jan 15, 2025 |
| Jan 13, 2025 | David W Heard Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +650,000 | $0.00 | $0 | 650,000 | Jan 15, 2025 |
| Jan 13, 2025 | Nicholas Walden SVP, Worldwide Sales | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | Jan 15, 2025 |
| Jan 13, 2025 | Regan J MacPherson Chief Legal Officer | AGrant or award Restricted Stock Unitsderivative | +50,000 | $0.00 | $0 | 50,000 | Jan 15, 2025 |
| Jan 5, 2025 | David W Heard Chief Executive Officer | MOption exercise Common Stock | +28,125 | $0.00 | $0 | 1,108,905 | Jan 7, 2025 |
| Jan 5, 2025 | David F Welch director | MOption exercise Common Stockindirect: See Footnote | +8,333 | $0.00 | $0 | 435,320 | Jan 7, 2025 |
| Jan 5, 2025 | Nicholas Walden SVP, Worldwide Sales | MOption exercise Common Stock | +5,416 | $0.00 | $0 | 172,322 | Jan 7, 2025 |
| Jan 5, 2025 | Nancy Erba Chief Financial Officer | MOption exercise Common Stock | +9,791 | $0.00 | $0 | 581,713 | Jan 7, 2025 |
| Jan 5, 2025 | David W Heard Chief Executive Officer | FTax withholding Common Stock | -8,416 | $6.59 | $55k | 1,100,489 | Jan 7, 2025 |
| Jan 5, 2025 | Nancy Erba Chief Financial Officer | FTax withholding Common Stock | -5,491 | $6.59 | $36k | 576,222 | Jan 7, 2025 |
| Jan 5, 2025 | Nicholas Walden SVP, Worldwide Sales | FTax withholding Common Stock | -2,681 | $6.59 | $18k | 169,641 | Jan 7, 2025 |
| Jan 5, 2025 | David F Welch director | FTax withholding Common Stockindirect: See Footnote | -2,450 | $6.59 | $16k | 432,870 | Jan 7, 2025 |
| Jan 5, 2025 | David W Heard Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -28,125 | $0.00 | $0 | 140,624 | Jan 7, 2025 |
| Jan 5, 2025 | Nicholas Walden SVP, Worldwide Sales | MOption exercise Restricted Stock Unitsderivative | -5,416 | $0.00 | $0 | 27,084 | Jan 7, 2025 |
| Jan 5, 2025 | Nancy Erba Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -9,791 | $0.00 | $0 | 48,959 | Jan 7, 2025 |
| Jan 5, 2025 | David F Welch director | MOption exercise Restricted Stock Unitsderivative | -8,333 | $0.00 | $0 | 41,667 | Jan 7, 2025 |
| Dec 5, 2024 | Nancy Erba Chief Financial Officer | MOption exercise Common Stock | +7,708 | $0.00 | $0 | 576,066 | Dec 6, 2024 |
| Dec 5, 2024 | David W Heard Chief Executive Officer | MOption exercise Common Stock | +19,259 | $0.00 | $0 | 1,089,540 | Dec 6, 2024 |
| Dec 5, 2024 | David F Welch director | MOption exercise Common Stockindirect: See Footnote | +8,333 | $0.00 | $0 | 429,700 | Dec 6, 2024 |
| Dec 5, 2024 | Nicholas Walden SVP, Worldwide Sales | MOption exercise Common Stock | +5,333 | $0.00 | $0 | 169,009 | Dec 6, 2024 |
| Dec 5, 2024 | Nancy Erba Chief Financial Officer | FTax withholding Common Stock | -4,144 | $6.63 | $27k | 571,922 | Dec 6, 2024 |
| Dec 5, 2024 | David F Welch director | FTax withholding Common Stockindirect: See Footnote | -2,713 | $6.63 | $18k | 426,987 | Dec 6, 2024 |
| Dec 5, 2024 | Nicholas Walden SVP, Worldwide Sales | FTax withholding Common Stock | -2,103 | $6.63 | $14k | 166,906 | Dec 6, 2024 |
| Dec 5, 2024 | David W Heard Chief Executive Officer | FTax withholding Common Stock | -8,760 | $6.63 | $58k | 1,080,780 | Dec 6, 2024 |
| Dec 5, 2024 | David W Heard Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -19,259 | $0.00 | $0 | 19,260 | Dec 6, 2024 |
| Dec 5, 2024 | Nicholas Walden SVP, Worldwide Sales | MOption exercise Restricted Stock Unitsderivative | -5,333 | $0.00 | $0 | 5,334 | Dec 6, 2024 |
| Dec 5, 2024 | Nancy Erba Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -7,708 | $0.00 | $0 | 7,709 | Dec 6, 2024 |
| Dec 5, 2024 | David F Welch director | MOption exercise Restricted Stock Unitsderivative | -8,333 | $0.00 | $0 | 8,334 | Dec 6, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Christine Bucklindirector
- Greg Doughertydirector
- Nancy ErbaChief Financial Officer
- David W HeardChief Executive Officer
- Sharon E Holtdirector
- Roop Kalyan Lakkarajucfo, officer, director
- Paul J Milburydirector
- Regan J MacPhersonChief Legal Officer
- George Andrew Riedeldirector
- Nicholas WaldenSVP, Worldwide Sales
- David F Welchdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.